Carmofur (10 mg/kg, orally) effectively suppressed FAAH and NAAA activities (Figure S1) and increased the levels of all three FAEs in lungs in ALI mice, which was in agreement with the in vitro results. This evidence concerns the gene FAAH and acute respiratory distress syndrome.